Stoke Therapeutics

0 followers


Stoke Therapeutics is pioneering a new way to treat the underlying causes of severe genetic diseases by precisely upregulating protein expression.

Industries

Headquarters

Stage

Employees

Links

Org chart

Edward M. Kaye
CEO & Director

Edward M. Kaye

Collapse
Dawn Kalmar
Chief Communications Officer
Barry S. Ticho
Chief Medical Officer
Shamim Ruff
Chief Regulatory Officer
Huw M. Nash
Chief Operating & Business Officer
Jonathan Allan
General Counsel
Isabel Aznarez
Co-Founder & VP, Discovery Research
Meena
VP, Bioanalytical, DMPK & Biomarker Development
Christy Chaves Blaney
Director, Talent Acquisition
Eric Rojas
Vice President, Head of Investor Relations
James Stutely
Head, Clinical Data Management
Kimberly Parkerson
Vice President, Head of Neurology Clinical Development
Lorene Kush
Executive Assistant To Chief Executive Officer
Malini Viswanathan Ph.D
Vice President Portfolio and Alliance Management
Parisa S.
Executive Director, Patient Advocacy, Policy, And Stakeholder Engagement
Samuel Manoranjan
Vice President of Quality
Stephen Yu
VP Head of IT
Jason Hoitt
Chief Commercial Officer (cco)